Nucleic acid therapeutics have the versatile ability to address a large number of health conditions by targeting their genetic blueprints. Historically, nucleic acid therapeutic drugs have treated severe and fatal conditions such as malignant tumors, hereditary neuromuscular atrophy, and hereditary thyroxine-mediated amyloidosis. With Jade Biotech’s developments in nucleic acid and oligonucleotide synthesis, our nucleotide technologies help the pharmaceutical industry develop more vital treatments and biomedical technologies, including novel mRNA vaccines, improved high throughput screening and biomedical imaging techniques, and specialized nucleic acid therapies.
Our goal is to achieve industrial scale production of our high value added products in a sustainable and environmentally-friendly way.
We are dedicated to assisting the nucleic acid therapeutics industry in finding the next breakthrough in gene technology.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.